![conference banner](/images/conference-banner.jpeg)
Abstract
The human ras genes (Nras, Hras, and Kras) code for closely related small GTPases possessing a molecular size of about 21 KDa. Ras proteins operate as molecular switches in signal transduction cascades controlling cell proliferation, differentiation or apoptosis. As for all G proteins, the function of the ras gene protein products is controlled through a regulated GDP / GTP cycle. Each of the three human ras proto-oncogenes can give rise to a transforming oncogene via single base pair mutations. Mutations at codons 12, 13 or 61 significantly downgrade the GTPase ability of the resulting mutant Ras proteins, which are thus rendered constitutively active and able to transform mammalian cells. Indeed, the detection of such mutations in various human tumors indicates that deregulated GTP binding to Ras is involved in the development of up 30% of all human cancers. Specific members of the Ras family are mutated in different tumor types, with mutations in Kras appearing most frequently. Some tumor cell lines harbor amplified ras genes and transfection studies have shown that a 20-fold increase in the level of expressed normal Ras protein is sufficient to induce transformation of some recipient cells. Studies with knockout mice strains have revealed that Kras (but not Nras or Hras) is necessary and sufficient for the development of the animals to the adult stage. It remains unclear whether the different Ras family members play totally specific or overlapping functional roles in the cell. Recent data on localization to different plasma membrane subdomains, marked quantitative differences of effector activation levels and new roles for some docking / scaffold proteins point to signaling specificities of the different Ras proteins. This review analyzes the current understanding of Ras function focusing on the possible physiological and oncogenic specificities of each Ras family member.
Keywords: ras gene, nras,hras,kras, ras protein, photo-oncogene
Current Genomics
Title: ras Genes and Human Cancer: Different Implications and Different Roles
Volume: 3 Issue: 4
Author(s): Jose M. Rojas and Eugenio Santos
Affiliation:
Keywords: ras gene, nras,hras,kras, ras protein, photo-oncogene
Abstract: The human ras genes (Nras, Hras, and Kras) code for closely related small GTPases possessing a molecular size of about 21 KDa. Ras proteins operate as molecular switches in signal transduction cascades controlling cell proliferation, differentiation or apoptosis. As for all G proteins, the function of the ras gene protein products is controlled through a regulated GDP / GTP cycle. Each of the three human ras proto-oncogenes can give rise to a transforming oncogene via single base pair mutations. Mutations at codons 12, 13 or 61 significantly downgrade the GTPase ability of the resulting mutant Ras proteins, which are thus rendered constitutively active and able to transform mammalian cells. Indeed, the detection of such mutations in various human tumors indicates that deregulated GTP binding to Ras is involved in the development of up 30% of all human cancers. Specific members of the Ras family are mutated in different tumor types, with mutations in Kras appearing most frequently. Some tumor cell lines harbor amplified ras genes and transfection studies have shown that a 20-fold increase in the level of expressed normal Ras protein is sufficient to induce transformation of some recipient cells. Studies with knockout mice strains have revealed that Kras (but not Nras or Hras) is necessary and sufficient for the development of the animals to the adult stage. It remains unclear whether the different Ras family members play totally specific or overlapping functional roles in the cell. Recent data on localization to different plasma membrane subdomains, marked quantitative differences of effector activation levels and new roles for some docking / scaffold proteins point to signaling specificities of the different Ras proteins. This review analyzes the current understanding of Ras function focusing on the possible physiological and oncogenic specificities of each Ras family member.
Export Options
About this article
Cite this article as:
Rojas M. Jose and Santos Eugenio, ras Genes and Human Cancer: Different Implications and Different Roles, Current Genomics 2002; 3 (4) . https://dx.doi.org/10.2174/1389202023350381
DOI https://dx.doi.org/10.2174/1389202023350381 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.
This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that ...read more
Related Journals
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Elucidation of Abnormal Extracellular Regulated Kinase (ERK) Signaling and Associations with Syndromic and Non-syndromic Autism
Current Drug Targets Mechanism of Conjugated Imine and Iminium Species, including Marine Alkaloids: Electron Transfer, Reactive Oxygen Species, Therapeutics and Toxicity
Current Bioactive Compounds Costimulation, Coinhibition and Cancer
Current Cancer Drug Targets Sarcosine-Based Glycine Transporter Type-1 (GlyT-1) Inhibitors Containing Pyridazine Moiety: A Further Search for Drugs with Potential to Influence Schizophrenia Negative Symptoms
Current Pharmaceutical Design Lipid Membranes and β-Amyloid: A Harmful Connection
Current Protein & Peptide Science The Wnt Pathway in Mood Disorders
Current Neuropharmacology Protein Amyloidogenesis Investigated by Small Angle Scattering
Current Pharmaceutical Design Tumor Targeting with RGD Peptide Ligands-Design of New Molecular Conjugates for Imaging and Therapy of Cancers
Anti-Cancer Agents in Medicinal Chemistry MicroRNAs: Potential Diagnostic and Therapeutic Targets for Breast Cancer
Epigenetic Diagnosis & Therapy (Discontinued) 5-ht6 Receptors
Current Drug Targets - CNS & Neurological Disorders Endoplasmic Reticulum Protein Quality Control in Neurodegenerative Disease: The Good, the Bad and the Therapy
Current Medicinal Chemistry Green Chemistry Approach as a Versatile Platform for Nanoparticles with Biomedical Applications
Nanoscience & Nanotechnology-Asia Cerium Oxide Nanoparticles Trigger Neuronal Survival in a Human Alzheimer Disease Model By Modulating BDNF Pathway
Current Nanoscience Cdc25A Protein Phosphatase: A Therapeutic Target for Liver Cancer Therapies
Anti-Cancer Agents in Medicinal Chemistry Properties of Neurotoxic Peptides Related to the Bri Gene
Protein & Peptide Letters Microdialysis: A Technique for Pharmacokinetic-Pharmacodynamic Studies of Oncological Drugs
Current Pharmaceutical Biotechnology Neuroglobin and Estrogen Receptors: A New Pathway of Cell Survival and Cell Death Balance
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) miRNA-497 Enhances the Sensitivity of Colorectal Cancer Cells to Neoadjuvant Chemotherapeutic Drug
Current Protein & Peptide Science Familial Alzheimers Disease Mutations in Presenilin 1 Do Not Alter Levels of the Secreted Amyloid-β Protein Precursor Generated by β-Secretase Cleavage
Current Alzheimer Research Practical Issues in Stem Cell Therapy for Alzheimers Disease
Current Alzheimer Research